SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem informs about newspaper publication

16 Aug 2024 Evaluate
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, NGL Fine-Chem has informed that it enclosed copies of the newspaper publication of Financial Results as on 30th June, 2024, published in Free Press Journal and Navshakti on Wednesday 14th August, 2024.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

2250.95 -4.10 (-0.18%)
17-Apr-2026 11:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.80
Dr. Reddys Lab 1222.85
Cipla 1239.25
Zydus Lifesciences 944.50
Lupin 2319.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×